Biotech China 2014

Antibodies: Pfizer

Total Score People Score Events Score
37 34 25
Date Event Presentation Speakers
June 4, 2013 World Pharma Congress Luncheon Presentation I: Use of Micropatterned Cocultures (MPCC) to Detect Compounds That Cause Drug-Induced Liver Injury in Humans Yvonne Will
A More Holistic Approach to Drug Design Concepts in Minimizing Cell-Based Target Organ Toxicity Yvonne Will, Michael Aleo
Chairperson’s Opening Remarks Yvonne Will
Plenary Keynote Panel Discussion: Advancing Pharma R&D through Communication & Collaborations: Bio-Connectivity at Work Karim Dabbagh
June 3, 2013 Asia Biotech Invest 2013 Commercialising innovation – Biotech business models for future growth Yuan-Hua Ding
February 10, 2013 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs Plenary: Transforming Drug Discovery for Complex Diseases: A Systems Biology Approac Piet Van Der Graaf
November 29, 2011 The 7th annual European Antibody Congress is the worldleading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Free or total therapeutic monoclonal antibody concentration monitoring Bing Kuang
January 13, 2011 Second Annual Protein Aggregation and Emerging Analytical Tools Structure-Based Design of Therapeutic Antibodies for Improved Developability Sandeep Kumar
January 13, 2011 Inaugural Protein Computational Tools Structure-Based Design of Therapeutic Antibodies for Improved Developability Sandeep Kumar
January 13, 2011 Inaugural Antibody Drug Products CovX-Bodies: A New Scaffold for Antibody Conjugates Joel Desharnais
January 13, 2011 Fourteenth Annual Overcoming Protein Expression Challenges with Solutions Expression, Purification and Characterization of Biologically Active Human AMPActivated Protein Kinase (AMPK) Heterodimeric Complexes Francis Rajamohan
January 12, 2011 Antibodies for the 21st Century Immunoconjugates for Oncology: Fewer Barriers to Delivering Cytotoxicity Now? Alejandro D. Ricart
January 11, 2011 Fourteenth Annual Choosing, Designing, and Optimizing Hosts and Platforms Use of the Design-of-Experiments Approach for the Development of a Refolding Technology for Progenipoietin-1, a Recombinant Human Cytokine Fusion Protein from Escherichia coli Inclusion Bodies Denis M. Boyle
January 10, 2011 Third Annual Optimizing Biologics Formulation Development Rational Choice of Excipients for Lyophilized Formulations Evgenyi Shalaev
May 20, 2010 Bioanalytical Challenges for Optimizing Protein Therapeutics Free and Total Immunoassays for Monoclonal Antibodies to Soluble Targets and Target as Biomarker Lindsay King
Design of Experiments: Case Studies from a Bioanalytical Lab Franklin Spriggs
The Impact of Shed Target Antigen on the Quantitation of Therapeutic mAb and its Pharmacokinetics Implication Bing Kuang
May 20, 2010 Antibody Optimization Antibody-Drug Conjugates to Improve Therapeutic Index Wei Liao
Optimization of a Monoclonal Antibody for Improved Anti-Tumor Efficacy Gerald Casperson
Chairperson’s Opening Remarks Gerald Casperson
May 19, 2010 Engineering Antibodies Use of Disposable Label-Free Real-Time Biosensors in Epitope Binning Monoclonal Antibodies Yasmina Abdiche
May 19, 2010 Pre-Clinical / Clinical Development of Therapeutic Antibodies Species Selection: The Foundation of the Nonclinical Toxicology Program Marque Todd
May 17, 2010 Phage and Yeast Display of Antibodies and Proteins Determination of the True Diversity of a Human Antibody Library and Insights into the Human Antibody Repertoire, Using Next Generation DNA Sequencing Jaume Pons
May 4, 2010 Biomarker World Congress 2010 Pre-clinical Translational Biomarkers: Enabling Early Predictions Using PK/PD Mark Fidock
August 3, 2009 The Next Wave of Antibody Therapeutics Clinical Development of the IGF-IR inhibitor Figitumumab for the Treatment of Cancer Antonio Gualberto
December 7, 2008 Antibody Engineering Technology Workshops : Using the ProteOn to Characterize Antigen/Antibody Interactions Yasmina Abdiche
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Advances and Applications in Prediction of Biotransformation Pathways | Golden West Deepak Dalvie
Overview on the Role of Biotransformation in Drug Discovery Deepak Dalvie
Drug Metabolites and Toxicity: Experimental Approaches to Help Focus on What is Important Scott Obach
Determining Cross-Species Exposure-Receptor Occupancy Relationships for a Dual-Pharmacology CNS Compound: An Exercise in Translational Pharmacology. Christopher L. Shaffer
Determining Cross-Species Exposure-Receptor Occupancy Relationships for a Dual-Pharmacology CNS Compound: An Exercise in Translational Pharmacology. Christopher L. Shaffer
Structures of CYP3A4 Ligand Complexes: How Does Pharma Integrate this Information? Michael R. Wester
Structures of CYP3A4 Ligand Complexes: How Does Pharma Integrate this Information? Michael R. Wester
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Elective: Track A: Collaborations & Partnerships: Developing an Effective Partnership with Chinese Companies Steve Q. Yang
April 30, 2008 Assessment of Immunogenicity in Clinical Trials Cell-Based Versus Non-Cell Based Assays to Characterize Neutralizing Antibodies Deborah Finco Kent
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Exploring Chemical Space in Protein-Protein Inhibitor Drug Discovery Tomi Sawyer
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Chairperson's Opening Remarks (08:00-08:15) Ned Mozier
Assessing Structure/Function Relationships (08:15-10:45) Aparna Deora
Assessing Structure/Function Relationships :Protein Changes that Make a Difference: Measuring the Impact on Biopotency with Various Bioanalytical Methods (09:15-09:45) Aparna Deora
Causes and Assessment of Product and Process-Related Impurities (13:25-18:30) Peter J. Nicastro
Causes and Assessment of Product and Process-Related Impurities:Comparison of Techniques for Aggregate Measurement (14:00-14:30) Peter J. Nicastro
CMC Approaches to Specific and Emerging Biotech Products (09:15-10:45) Michael R Schlittler,
CMC Approaches to Specific and Emerging Biotech Products: Characterization of Synthetic Peptides for Biotechnology - Unique Challenges (09:15-09:45) Michael R Schlittler,
Process and Analytical Related Issues (15:30-17:00) Amit Banerjee
September 19, 2007 Drug Delivery Global Summit Successful Partnering in the Drug Delivery Market Place James Eshelby
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.